Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes

The insertion of a transgene downstream of the L3-23K or L5-Fiber region was reported as a vital strategy for arming E3 non-deleted oncolytic adenoviruses. However, depending on the percentage of codons with G/C at the third base position (GC3%) and the type of splicing acceptor, an insert downstream of the L5-Fiber region may substantially affect virus fitness. Since the insertion of transgenes downstream of the L3-23K and L5-Fiber regions has never been compared in terms of their expression levels and impact on virus fitness, we assessed the total virus yield, cytolytic efficacy, and plaque size of Ad5-delta-24-RGD (Ad5Δ24RGD) armed with <i>EGFP</i>, <i>FLuc</i>, the suppressor of RNA silencing <i>p19</i>, soluble wild-type human/mouse and high-affinity human programmed cell death receptor-1 (PD-1/<i>PDCD1</i>) ectodomains, and soluble human hyaluronidase PH20/<i>SPAM1</i>. The insertion of transgenes downstream of the L3-23K region ensures their production at considerably higher levels. However, the insertion of transgenes downstream of either region differentially and unpredictably affects the oncolytic potency of Ad5Δ24RGD, which cannot be explained by GC3% or expression level alone. Surprisingly, the expression of the human and mouse PD-1 ectodomains with 83.1% and 70.1% GC3%, respectively, does not affect cytolytic efficacy but increases the plaque size in a cell line-dependent manner.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2025-04-14
DOI
https://doi.org/10.3390/ijms26083700
Citations
3
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
5.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes

Aleksei A. Stepanenko, M. P. Valikhov, Anastasiia O. Sosnovtseva, Olga Abramova et al.
3 citations
International Journal of Molecular Sciences
Virus-based gene therapy research
5.45
article

Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes

Aleksei A. Stepanenko, M. P. Valikhov, Anastasiia O. Sosnovtseva, Olga Abramova, Anastasiya V. Lipatova, Gaukhar M. Yusubalieva, В. П. Чехонин, Anastasiia A. Vasiukova
article en
3 citations

Abstract

The insertion of a transgene downstream of the L3-23K or L5-Fiber region was reported as a vital strategy for arming E3 non-deleted oncolytic adenoviruses. However, depending on the percentage of codons with G/C at the third base position (GC3%) and the type of splicing acceptor, an insert downstream of the L5-Fiber region may substantially affect virus fitness. Since the insertion of transgenes downstream of the L3-23K and L5-Fiber regions has never been compared in terms of their expression levels and impact on virus fitness, we assessed the total virus yield, cytolytic efficacy, and plaque size of Ad5-delta-24-RGD (Ad5Δ24RGD) armed with <i>EGFP</i>, <i>FLuc</i>, the suppressor of RNA silencing <i>p19</i>, soluble wild-type human/mouse and high-affinity human programmed cell death receptor-1 (PD-1/<i>PDCD1</i>) ectodomains, and soluble human hyaluronidase PH20/<i>SPAM1</i>. The insertion of transgenes downstream of the L3-23K region ensures their production at considerably higher levels. However, the insertion of transgenes downstream of either region differentially and unpredictably affects the oncolytic potency of Ad5Δ24RGD, which cannot be explained by GC3% or expression level alone. Surprisingly, the expression of the human and mouse PD-1 ectodomains with 83.1% and 70.1% GC3%, respectively, does not affect cytolytic efficacy but increases the plaque size in a cell line-dependent manner.

International Journal of Molecular SciencesVol. 26(8)
Engelhardt Institute of Molecular Biology (RU), Pirogov Russian National Research Medical University (RU), Ministry of Health of the Russian Federation (RU), Federal Medical Research Centre for Psychiatry and Narcology (RU), Federal Medical-Biological Agency (RU)
Russian Science Foundation, Ministry of Health of the Russian Federation
Good health and well-being
Openalex Percentile: Top 5%
Virus-based gene therapy research
5.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.